This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Genzyme: Analysts' Upgrades, Downgrades

Analog Devices (ADI) estimates, target boosted at Goldman. ADI estimates were increased through 2011. Company is realizing higher margin leverage. Buy rating and new $37 price target.

Applied Materials (AMAT - Get Report) estimates raised at Goldman. AMAT estimates were increased through 2011. Company is seeing strong silicon orders. Buy rating and $17 price target.

CF Industries (CF) numbers increased at UBS. CF estimates were raised through 2011. Company is seeing higher demand for Nitrogen and Phosphate. Neutral rating and new $104 price target.

Chesapeake Energy (CHK) estimates raised at UBS through 2010. Company guided toward higher production growth. Neutral rating and $29 price target.

Darden Restaurants (DRI) numbers upped at Goldman Shares of DRI now seen reaching 2012. Estimates also boosted, to reflect better sales and margins. Neutral rating and new $44 price target.

Devon Energy (DVN) estimates boosted at Goldman through 2011. Company is seeing higher production rates and lower costs. Buy rating and $96 price target.

EMC (EMC) target upped at UBS. Shares of EMC now seen reaching $21. Company likely to benefit from momentum at VMW. Buy rating.

FMC Technologies (FTI) price target raised at Credit Suisse. FTI price target jumped to $57 from $54 after solid 4Q09 results. 2010 and 2011 EPS estimates increased to $2.60 and $2.90, respectively. Maintain Neutral rating.

FMC Technologies (FTI) numbers upped at FBR. Shares of FTI now seen reaching $77. Estimates also boosted, as the company has tremendous order potential in 2010. Outperform rating.
3 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AEO $14.31 0.00%
AMAT $20.47 0.00%
BHI $48.36 0.00%
DE $84.11 0.00%
HPQ $12.27 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs